News & Perspective

Feb 10, 2017

Feb 10, 2017

News Scan for Feb 10, 2017

Saudi MERS case
Senate confirms HHS pick
Avian flu update

Dec 22, 2014

Dec 22, 2014
Package of Rapivab (peramivir), a flu drug

FDA approval of peramivir makes IV flu drug available

Peramivir, made by BioCryst, is intended to be given to influenza patients in a single intravenous dose.

Sep 02, 2014

Sep 02, 2014

Ebola Scan for Sep 02, 2014

HHS funds for ZMapp
China's Ebola drug approval
30-minute Ebola test

Apr 17, 2014

Apr 17, 2014

News Scan for Apr 17, 2014

H5N1, H5N8 updates
New NBSB advisors
Valley fever in TV film crew
Pakistani army fights polio

Feb 07, 2013

Feb 07, 2013

Researchers find first US evidence of vaccine-resistant pertussis

(CIDRAP News) – Researchers in other countries have found evidence that circulating strains of Bordetella pertussis have adapted to the acellular vaccine, and researchers today reported similar findings for the first time in US kids, based on genetic analysis of isolates from hospitalized children.

Jan 23, 2013

Jan 23, 2013

Research moratorium on modified H5N1 viruses ends

(CIDRAP News) – A year-long voluntary moratorium on research involving transmissible H5N1 avian flu viruses ended today with a letter from a group of scientists that supports resuming the work in countries that have addressed the biosafety issues involved.

Dec 11, 2012

Dec 11, 2012

HHS offers some forecasts on medical countermeasures

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

Pages

Sort Results

 

Narrow results

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»